These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 20683775)
1. Efficacy of akatinol memantine in moderate cognitive impairments. Levin OS; Yunishchenko NA; Dudarova MA Neurosci Behav Physiol; 2010 Oct; 40(8):926-33. PubMed ID: 20683775 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy of acatinol memantine in mild cognitive disorder]. Levin OS; Iunishchenko NA; Dudarova MA Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):36-42. PubMed ID: 19672236 [TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial]. Hu HT; Zhang ZX; Yao JL; Yu HZ; Wang YH; Tang HC; Ji CJ; Xu T Zhonghua Nei Ke Za Zhi; 2006 Apr; 45(4):277-80. PubMed ID: 16780671 [TBL] [Abstract][Full Text] [Related]
4. [Akatinol memantine in patients with vascular cognitive disorders]. Gudkova AA; Sorokina IB; Iakovlev AA; Guliaeva NV; Gekht AB Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):37-40. PubMed ID: 21311485 [TBL] [Abstract][Full Text] [Related]
5. [Clinical features of the formation and possibilities of treatment of posttraumatic cognitive disturbances]. Litvinenko IV; Emelin AIu; Vorob'ev SV; Lobzin VIu Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):60-6. PubMed ID: 21311490 [TBL] [Abstract][Full Text] [Related]
6. [Akatinol memantine in the therapy of cognitive disorders in Parkinson's disease]. Puzin MN; Krivonos OV; Kozhevnikova ZhV Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(1):26-9. PubMed ID: 17310793 [TBL] [Abstract][Full Text] [Related]
7. [Multi-center open comparative randomized study of efficacy and safety of Akatinol Memantine 20 mg (single-doses) vs Akatinol Memantine 10 mg (double-doses) in patients with vascular dementia]. Gavrilova SI; Kolykhalov IV; Mikhaylova NM; Ponomareva EV; Fedorova YB; Medvedev VE; Frolova VI; Gushanskaya EV; Litvinenko IV; Emelin AY; Lobzin VY; Kashin AV; Tanashyan MM; Kachanova MV; Knyazev AV; Gonik MI Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):69-77. PubMed ID: 38465812 [TBL] [Abstract][Full Text] [Related]
8. Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia. Litvinenko IV; Odinak MM; Mogil'naya VI; Perstnev SV Neurosci Behav Physiol; 2010 Feb; 40(2):149-55. PubMed ID: 20033305 [TBL] [Abstract][Full Text] [Related]
9. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia]. Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850 [TBL] [Abstract][Full Text] [Related]
10. The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia. Cheon Y; Park J; Joe KH; Kim DJ Int J Neuropsychopharmacol; 2008 Nov; 11(7):971-83. PubMed ID: 18346293 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy, safety and tolerability of a single dose of akatinol memantine in comparison to two-doses in patients with moderately expressed and moderately severe dementia in Alzheimer's disease]. Kolykhalov IV; Gavrilova SI; Kalyn IaB; Selezneva ND; Fedorova IaB Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(1):35-9. PubMed ID: 22678673 [TBL] [Abstract][Full Text] [Related]
12. Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial. Schulz JB; Rainer M; Klünemann HH; Kurz A; Wolf S; Sternberg K; Tennigkeit F J Alzheimers Dis; 2011; 25(3):463-75. PubMed ID: 21471647 [TBL] [Abstract][Full Text] [Related]
14. [The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)]. Bugrova SG; Novikov AE Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):44-8. PubMed ID: 18379503 [TBL] [Abstract][Full Text] [Related]
15. [Akatinol memantin in Alzheimer's disease: clinico-immunological correlates]. Androsova LV; Selezneva ND Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(9):36-8. PubMed ID: 11026134 [TBL] [Abstract][Full Text] [Related]
16. [Use of omaron in patients with post-stroke cognitive disorders]. Parfenov VA; Belavina GR; Vakhnina NV; Gusev VV; Levin IaI; Markin SP; Starchina IuA Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):41-5. PubMed ID: 19672226 [TBL] [Abstract][Full Text] [Related]